Patents by Inventor Daniel Greff
Daniel Greff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260053865Abstract: The invention relates to a product for topical use in the treatment of skin affected by dysbiosis. The product has a pH ranging from 5.5 to 6.5 and essentially comprises water, glycerin and at least one crosslinked polyacrylate. This product can be used as a prerequisite for the transplantation of biological material favorable to the development of a healthy cutaneous bacterial flora.Type: ApplicationFiled: November 4, 2025Publication date: February 26, 2026Applicant: BiopassInventor: Daniel Greff
-
Publication number: 20260053741Abstract: The invention relates to a product for treating viral diseases, such as COVID-19, via the nasal route. The product comprises a hydrogel based on water, glycerol and a carbomer.Type: ApplicationFiled: November 3, 2025Publication date: February 26, 2026Inventors: Stéphanie AUDRAN, Daniel GREFF
-
Patent number: 12458671Abstract: The disclosure relates to a product for topical use in the treatment of skin affected by dysbiosis. The product has a pH ranging from 5.5 to 6.5 and essentially includes water, glycerin and at least one crosslinked polyacrylate. This product can be used as a prerequisite for the transplantation of biological material favorable to the development of a healthy cutaneous bacterial flora.Type: GrantFiled: January 13, 2020Date of Patent: November 4, 2025Assignee: BIOPASSInventor: Daniel Greff
-
Publication number: 20230330013Abstract: The invention relates to a product for treating viral diseases, such as COVID-19, via the nasal route. The product comprises a hydrogel based on water, glycerol and a carbomer.Type: ApplicationFiled: August 3, 2021Publication date: October 19, 2023Inventors: Stéphanie AUDRAN, Daniel GREFF
-
Publication number: 20220331603Abstract: The invention disclosure relates to a device for emitting a magnetic field including an insulating support intended to be applied on a part of a person's body, at least two hexagonal antennas, and a power supply source. The device has at least a first antenna and at least a second antenna, that are reversely wound.Type: ApplicationFiled: August 4, 2020Publication date: October 20, 2022Applicant: Biopass S.A.Inventor: Daniel Greff
-
Publication number: 20220080000Abstract: The disclosure relates to a product for topical use in the treatment of skin affected by dysbiosis. The product has a pH ranging from 5.5 to 6.5 and essentially includes water, glycerin and at least one crosslinked polyacrylate. This product can be used as a prerequisite for the transplantation of biological material favorable to the development of a healthy cutaneous bacterial flora.Type: ApplicationFiled: January 13, 2020Publication date: March 17, 2022Applicant: BiopassInventor: Daniel Greff
-
Patent number: 9962402Abstract: The present invention relates to a hygiene product or a pharmaceutical composition in the form of a gel or dressing, for topical application to the skin or mucosa including glycerol, at least one poly(meth)acrylate polymer, at least one polyethylene glycol having a molecular weight of less than 1000 g/mol, octanediol and water. The composition or dressing can be used for healing treatment of chronic dermal ulcers, healing and soothing treatment of eczema and psoriatic conditions, healing treatment of anal fissures, treatment of mouth injuries, resorption and healing of labial herpes (cold sore) and treatment of dermatitis. The hygiene product can be a shaving or aftershave product for sensitive or hypersensitive skin, a nasal decongestant product or a product for ear hygiene.Type: GrantFiled: April 5, 2012Date of Patent: May 8, 2018Assignee: BIOPASS S.A.Inventor: Daniel Greff
-
Patent number: 9403028Abstract: The invention relates to a device that can be used to expose a person to a magnetic field, including an insulating belt to be placed in contact with a part of the body of the person, at least one substantially rectangular, flat dipole antenna emitting a magnetic field over a vector perpendicular to the surface thereof, the antenna being arranged longitudinally on the belt in the lengthwise direction thereof, and a power source for supplying the antenna with AC or pulsed power.Type: GrantFiled: January 20, 2012Date of Patent: August 2, 2016Assignee: COSMOSOFTInventor: Daniel Greff
-
Publication number: 20140044667Abstract: The present invention relates to a hygiene product or a pharmaceutical composition in the form of a gel or dressing, for topical application to the skin or mucosa including glycerol, at least one poly(meth)acrylate polymer, at least one polyethylene glycol having a molecular weight of less than 1000 g/mol, octanediol and water. The composition or dressing can be used for healing treatment of chronic dermal ulcers, healing and soothing treatment of eczema and psoriatic conditions, healing treatment of anal fissures, treatment of mouth injuries, resorption and healing of labial herpes (cold sore) and treatment of dermatitis. The hygiene product can be a shaving or aftershave product for sensitive or hypersensitive skin, a nasal decongestant product or a product for ear hygiene.Type: ApplicationFiled: April 5, 2012Publication date: February 13, 2014Applicant: BIOPASS S.A.Inventor: Daniel Greff
-
Publication number: 20130331637Abstract: The invention relates to a device that can be used to expose a person to a magnetic field, including an insulating belt to be placed in contact with a part of the body of the person, at least one substantially rectangular, flat dipole antenna emitting a magnetic field over a vector perpendicular to the surface thereof, the antenna being arranged longitudinally on the belt in the lengthwise direction thereof, and a power source for supplying the antenna with AC or pulsed power.Type: ApplicationFiled: January 20, 2012Publication date: December 12, 2013Applicant: COSMOSOFTInventor: Daniel Greff
-
Patent number: 8295942Abstract: The adipose areas of the body are simultaneously subjected to lipolysis, through the action of an apparatus that generates low-frequency electromagnetic waves, to extraction, out of the adipose cells, of the fatty acids released by the lipolysis, and to drainage of the fatty acids to the vascular and lymphatic system, through the action of a pressotherapy apparatus.Type: GrantFiled: October 8, 2007Date of Patent: October 23, 2012Assignee: Biopass S.A.Inventor: Daniel Greff
-
Publication number: 20110066087Abstract: The adipose areas of the body are simultaneously subjected to lipolysis, through the action of an apparatus that generates low-frequency electromagnetic waves, to extraction, out of the adipose cells, of the fatty acids released by the lipolysis, and to drainage of the fatty acids to the vascular and lymphatic system, through the action of a pressotherapy apparatus.Type: ApplicationFiled: October 8, 2007Publication date: March 17, 2011Applicant: H.C.A. SA (SOCIETE DE DROIT LUXEMBOURGEOIS)Inventor: Daniel Greff
-
Publication number: 20070174903Abstract: A method and system for managing user identities on a network is disclosed. form independent model for managing user identities on a network is disclosed which translated to one or more platform-specific models for the actual implementation. An trator is provided with the ability to add, modify and delete actors on the network. or, such as a help desk, is ascribed use cases, such as enabling passwords, resetting s, and disenabling passwords, that are appropriate for that actor. The administrator modify each use case, such as by unlocking a user's account before resetting the d or providing an email notification to a user prior to resetting a password, to the desired by the administrator. As a result, an actor with no or little programming skills form sophisticated identity management functions resulting in improved efficiency and lower cost to the company.Type: ApplicationFiled: January 26, 2006Publication date: July 26, 2007Inventor: Daniel Greff
-
Patent number: 6372717Abstract: The invention concerns the use of peptides of general formula R1-L-Tyr-L-Arg-R2 in which R1=H or a R3-C=0 with R3=a C1 to C20 alkyl chain, linear or branched, saturated or unsaturate, hydroxylated or not, or with R3=an aryl, aryl-alkyl or alkyloxy or aryloxy or arylalkyloxy group, and in which R2=OH or a O-R4 group with R4=a C1 to C20 alkyl chain, or R2=a NH2, NHX or NXX group with X=a C1 to C4 alkyl chain. The peptides have a soothing effect on the skin, including by topical application, and attenuates the effects of benign skin sores (after shave irritation, sunstroke, frostbite, chaps, depilation). They are used in acceptable cosmetic excipients and in effective in vivo concentrations.Type: GrantFiled: February 23, 1999Date of Patent: April 16, 2002Assignee: Sederma S.A.Inventor: Daniel Greff
-
Patent number: 6123953Abstract: The use of alkane-1,2-diols for inactivating skin microorganisms by topical application includes 1,2-Octanediol used against the germs that cause acne and dandruff, as well as those that cause mastitis in dairy animals, and its activity strengthened by a synergistic interaction with gels such as glycerol poly(meth)acrylate.Type: GrantFiled: August 18, 1998Date of Patent: September 26, 2000Assignee: STOA S.A.Inventor: Daniel Greff
-
Patent number: 5891428Abstract: A gel, in a proportion of 1 to 20% of the finished product, contains at least one polyol, one (meth)acrylic acid polymer and one fluidification solvent of general formula (1): R1--O--(R2--O--R2).sub.n,--OR3, wherein R1 is a hydrogen atom or a straight or branched C1-C5 alkyl chain, R2 is a straight or branched C1-C5 alkyl chain, R3 is a hydrogen atom or a straight or branched C1-C5 alkyl chain, and n is an integer of 1 to 200,000.Type: GrantFiled: February 18, 1998Date of Patent: April 6, 1999Assignee: Sederma S.A.Inventor: Daniel Greff
-
Patent number: 4370315Abstract: The process consists in incorporating into the preparations enzymes called lipoxygenases together with their substrate named linoleic acid.The excipients of these preparations are chosen in a way as to ensure preservation of the active agents, easy spreading and rapid cutaneous absorption.The preparations from the invention are used to progressively reduce the growth of body hair after depilation. This reduction is perceptible after several depilatory operations followed by the application of these preparations.Type: GrantFiled: February 22, 1978Date of Patent: January 25, 1983Assignee: SedermaInventors: Daniel Greff, Francoise Petit-Martenon, Tran Toan